Last updated: July 28, 2021
Sponsor: Chang Gung Memorial Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cerebral Palsy
Treatment
N/AClinical Study ID
NCT04101994
201701518A0
Ages 5-20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of CP according to clinical criteria
- Age 5-20 years
- No use of botulinum toxin in the past 4 months
- No significant perceptual or communication disturbances
- No other peripheral or central nervous system dysfunction
- No active inflammatory or pathologic changes in upper limb joints during the previous 6 months
- No active medical problems, such as pneumonia, upper gastrointestinal bleeding, orurinary tract infection
- No active problems of epilepsy and EEG without epileptiform discharge
Exclusion
Exclusion Criteria:
- Metabolic disorders, such as inborn error of metabolism, electrolyte, and endocrinedisorders
- Active infectious disease, such as meningitis and encephalitis
- Patients with active medical problems, such as pneumonia, upper gastrointestinalbleeding, or urinary tract infection
- Poor compliance or intolerance for the TMS therapy
- Subjects with metallic implants or pregnancy.
- EEG show epileptiform discharge
- Patients with family history of epilipsy
- Patients with symptoms that are restricted from tDCS, such as epilepsy, migraine andunstable health condition
Study Design
Total Participants: 80
Study Start date:
June 26, 2018
Estimated Completion Date:
June 06, 2022
Study Description
Connect with a study center
Chang Gung Memorial Hospital
Taoyuan, 333
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.